Search Results - "proteins"
Suggested Topics within your search.
Suggested Topics within your search.
- therapeutic use
- Antibodies, Monoclonal 32
- drug therapy 23
- pharmacology 19
- chemistry 18
- metabolism 18
- Therapeutic use 17
- Drug Discovery 15
- Monoclonal antibodies 12
- genetics 12
- immunology 12
- Antineoplastic Agents 11
- pathology 11
- therapy 11
- Cancer 10
- Drug development 10
- Antineoplastic agents 9
- Enzymes 9
- Chemotherapy 8
- Immunotherapy 8
- Neoplasms 8
- Protein Kinase Inhibitors 8
- Protein-Tyrosine Kinases 8
- antagonists & inhibitors 8
- drug effects 8
- methods 8
- physiology 7
- Antibodies, Monoclonal, Humanized 6
- Antiviral Agents 6
- Design 6
-
1
Novel immunotherapeutic proteins immunoligand /
Published 2007Table of Contents: “…Contents: Potential advantages of mAB -- Challenges for mAB -- Antibody based therapeutic proteins -- Attributes of immunoligands -- Creation of Ig-based fusion proteins -- Non-cytolytic IL-2/Fc fusion protein -- Vaccine trial design -- Creation of cytolytic IL-15R antagonist fusion protein -- Application of immunoligand: immunogen for mAB production, to stain the cognate ligand, to identify cell surface cognate ligands via immunoprecipitation, to create long lived proteins to test the function of the targeting ligand in vivo and to modulate immune responses -- Challenges for immunoligands.…”
Get full text
Series
Electronic Video -
2
-
3
Novel immunotherapeutic proteins immunoligand /
Published 2007Table of Contents: “…Contents: Potential advantages of mAB -- Challenges for mAB -- Antibody based therapeutic proteins -- Attributes of immunoligands -- Creation of Ig-based fusion proteins -- Non-cytolytic IL-2/Fc fusion protein -- Vaccine trial design -- Creation of cytolytic IL-15R antagonist fusion protein -- Application of immunoligand: immunogen for mAB production, to stain the cognate ligand, to identify cell surface cognate ligands via immunoprecipitation, to create long lived proteins to test the function of the targeting ligand in vivo and to modulate immune responses -- Challenges for immunoligands.…”
Get full text
Series
Electronic Video -
4
-
5
Novel immunotherapeutic proteins immunoligand /
Published 2007Table of Contents: “…Contents: Potential advantages of mAB -- Challenges for mAB -- Antibody based therapeutic proteins -- Attributes of immunoligands -- Creation of Ig-based fusion proteins -- Non-cytolytic IL-2/Fc fusion protein -- Vaccine trial design -- Creation of cytolytic IL-15R antagonist fusion protein -- Application of immunoligand: immunogen for mAB production, to stain the cognate ligand, to identify cell surface cognate ligands via immunoprecipitation, to create long lived proteins to test the function of the targeting ligand in vivo and to modulate immune responses -- Challenges for immunoligands.…”
Get full text
Series
Electronic Video -
6
-
7
Innate immunity to retroelements by human AID/APOBEC3 proteins
Published 2007Table of Contents: “…Contents: Nucleic acid basics -- AID-related APOBEC3 proteins are DNA cytosine deaminases -- Retrovirus (e.g. …”
Get full text
Series
Electronic Video -
8
Innate immunity to retroelements by human AID/APOBEC3 proteins
Published 2007Table of Contents: “…Contents: Nucleic acid basics -- AID-related APOBEC3 proteins are DNA cytosine deaminases -- Retrovirus (e.g. …”
Get full text
Series
Electronic Video -
9
Innate immunity to retroelements by human AID/APOBEC3 proteins
Published 2007Table of Contents: “…Contents: Nucleic acid basics -- AID-related APOBEC3 proteins are DNA cytosine deaminases -- Retrovirus (e.g. …”
Get full text
Series
Electronic Video -
10
Fabry disease [alpha]-galactosidase A deficiency and enzyme replacement therapy /
Published 2007Subjects: Get full text
Series
Electronic Video -
11
Fabry disease [alpha]-galactosidase A deficiency and enzyme replacement therapy /
Published 2007Subjects: Get full text
Series
Electronic Video -
12
Fabry disease [alpha]-galactosidase A deficiency and enzyme replacement therapy /
Published 2007Subjects: Get full text
Series
Electronic Video -
13
CML genetic paradigm of targeted therapy, part 2 of 2 /
Published 2015Subjects: Get full text
Series
Electronic Video -
14
-
15
CML genetic paradigm of targeted therapy, part 2 of 2 /
Published 2015Subjects: Get full text
Series
Electronic Video -
16
CML genetic paradigm of targeted therapy, part 2 of 2 /
Published 2015Subjects: Get full text
Series
Electronic Video -
17
-
18
-
19
Receptor tyrosine kinase signaling and targeted therapies
Published 2022Subjects: Get full text
Series
Electronic Video -
20
Receptor tyrosine kinase signaling and targeted therapies
Published 2022Subjects: Get full text
Series
Electronic Video